文献速递冠心病外科

术前代谢综合征患者冠状动脉旁路移植术后不良事件:退伍军人数据库10年随访

Adverse events after coronary artery bypass grafting in patients with preoperative metabolic syndrome: A 10-year follow-up of the Veterans Affairs Database.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-08-12

本研究基于退伍军人数据库,比较合并代谢综合征(MET+)与不合并(MET-)的成人孤立性冠状动脉旁路移植(CABG)术后10年事件率。HR 1.3;

要点

  • MET+与复发性充血性心力衰竭再入院风险增加相关。

核心结论

  • 合并代谢综合征患者CABG术后10年心血管事件率更高,主要表现为心肌梗死和复发性心力衰竭再入院风险增加,但生存率相似。

研究设计与样本

  • 回顾性队列研究,纳入2005年1月1日至2014年12月31日在41个中心接受孤立性CABG的9615例退伍军人,随访至2019年10月31日。
  • 按代谢综合征存在(MET+)与否(MET-)分层,中位随访6.5年。
  • 采用多变量加权Cox模型分析全因死亡,竞争风险分析计算充血性心力衰竭、心肌梗死和脑血管事件的累积事件率,Fine-Gray亚分布模型确定MET与心肌梗死和卒中的调整关联,充血性心力衰竭采用复发性事件分析。

临床怎么用

  • 对合并代谢综合征的CABG患者,应加强术后心肌梗死和心力衰竭的监测与预防管理。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Data regarding 10-year survival and adverse cardiovascular events in patients with metabolic syndrome (MET) after coronary artery bypass grafting (CABG) is limited. METHODS: We compared 10-year events rates for veterans undergoing isolated CABG (January 1, 2005, to December 31, 2014, follow-up October 31, 2019) stratified by presence of metabolic syndrome (MET+) versus without (MET-). A multivariable weighted Cox model was used to analyze all-cause mortality. Competing risk analysis was used to calculate cumulative event rates for congestive heart failure, myocardial infarction, and cerebrovascular events. The Fine-Gray subhazard model was used to determine adjusted association of MET with myocardial infarction and stroke. Congestive heart failure was modeled as a recurrent-event analysis. RESULTS: Nationally, 9615 adults (median age, 60 years; 98.9% men) underwent isolated coronary artery bypass grafting at 41 centers); among them, 3121 out of 9615 (32.5%) had MET. The prevalence of MET increased from (27.88% in 2005 to 34.02% in 2014; P = .02). MET+ group members were likely younger (median age, 63 vs 64 years; P < .01), White (72% vs 68%), and had more peripheral vascular disease (30% vs 28%; P = .04). Multivessel (72% vs 70%; P = .23) and multiarterial (4% vs 4%; P = .14) grafting was performed equally. With a median follow-up of 6.5 years, survival was similar (P = .26); however, MET was associated with higher risks for myocardial infarction (21% vs 16%; hazard ratio, 1.3; P < .01) and recurrent admissions for congestive heart failure. CONCLUSIONS: Patients with metabolic syndrome undergoing coronary artery bypass grafting have higher 10-year cardiovascular event rates.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Deo SV, Sundaram V, Wilson B, et al. Adverse events after coronary artery bypass grafting in patients with preoperative metabolic syndrome: A 10-year follow-up of the Veterans Affairs Database. J Thorac Cardiovasc Surg. 2020. PMID: 32919773. doi:10.1016/j.jtcvs.2020.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。